US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organon & Co

12.20

+0.08000.66%

Post-market: 12.200.00000.00%19:44 EDT

Volume:2.73M

Turnover:33.24M

Market Cap:3.15B

PE:3.66

High:12.26

Open:12.04

Low:11.91

Close:12.12

Loading ...

Overview Company News Filings

Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for

BofA Securities Adjusts Price Target on Organon to $11 From $15, Maintains Underperform Rating

MT Newswires Live

Organon Appoints Ramona a. Sequeira to the Company’s Board of Directors

THOMSON REUTERS

Organon Appoints Ramona A. Sequeira to the Company’s Board of Directors

BRIEF-Organon & Co - Expects $6 Million Milestone Expense In Q1 2025

Press Release: Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025

Organon & Co - Expects $6 Million Milestone Expense in Q1 2025

THOMSON REUTERS

Health Canada Approves Nduvra™ (Tapinarof Cream), 1%, for the Topical Treatment of Plaque Psoriasis in Adults

THOMSON REUTERS

Morgan Stanley Sticks to Its Hold Rating for Organon (OGN)

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

Why Organon (OGN) Could Beat Earnings Estimates Again

Organon Acquires Tofidence for Intravenous Infusion in US

MT Newswires Live

Organon & Co - to Pay Tiered Royalties and Milestone Payments to Biogen

THOMSON REUTERS

Organon Acquires Tofidence™ (Tocilizumab-Bavi), a Commercialized Biosimilar to Actemra® (Tocilizumab) Injection, for Intravenous Infusion in the U.S.

THOMSON REUTERS

Organon & Co - Bio-Thera Solutions to Maintain Manufacturing Rights for Tofidence

THOMSON REUTERS

Organon, Henlius Say EMA Validates Marketing Authorization Application for Proposed Breast Cancer Drug

MT Newswires Live

BRIEF-European Medicines Agency (EMA) Validates Henlius And Organon Filing For Perjeta® (Pertuzumab) Biosimilar Candidate HLX11

European Medicines Agency (Ema) Validates Henlius and Organon Filing for Perjeta® (Pertuzumab) Biosimilar Candidate Hlx11

THOMSON REUTERS

European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11

Barclays Sticks to Its Buy Rating for Organon (OGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGN\",,,,,undefined,":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":12.2,"timestamp":1745611200000,"preClose":12.12,"halted":0,"volume":2732313,"hourTrading":{"tag":"盘后","latestPrice":12.2,"preClose":12.2,"latestTime":"19:44 EDT","volume":106875,"amount":1303877.63,"timestamp":1745624689496},"delay":0,"floatShares":256822726,"shares":257950149,"eps":3.33,"marketStatus":"Market Closed","change":0.08,"latestTime":"04-25 16:00:00 EDT","open":12.04,"high":12.255,"low":11.91,"amount":33238661.417451,"amplitude":0.028465,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.33,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":12.12,"dividendRate":0.091803,"preHourTrading":{"tag":"盘前","latestPrice":12.0699,"preClose":12.12,"latestTime":"09:11 EDT","volume":2239,"amount":27039.471576,"timestamp":1745586687506},"postHourTrading":{"tag":"盘后","latestPrice":12.2,"preClose":12.2,"latestTime":"19:44 EDT","volume":106875,"amount":1303877.63,"timestamp":1745624689496},"volumeRatio":0.5611338923905699,"impliedVol":0.7314,"impliedVolPercentile":0.956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGN\",,,,,undefined,":{"symbol":"OGN","floatShares":256822726,"roa":"7.39%","roe":"429.85%","lyrEps":3.361266,"volumeRatio":0.5611338923905699,"shares":257950149,"dividePrice":1.12,"high":12.255,"amplitude":0.028465,"preClose":12.12,"low":11.91,"week52Low":10.45,"pbRate":"6.67","psRate":"0.49","week52High":23.1,"institutionHeld":0,"latestPrice":12.2,"eps":3.33,"divideRate":0.091803,"volume":2732313,"delay":0,"ttmEps":3.33,"open":12.04,"prevYearClose":14.92,"prevWeekClose":11.12,"prevMonthClose":14.89,"prevQuarterClose":14.89,"fiveDayClose":11.12,"twentyDayClose":14.56,"sixtyDayClose":15.84,"earningDate":1746028800000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530951624","title":"Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for","url":"https://stock-news.laohu8.com/highlight/detail?id=2530951624","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530951624?lang=en_us&edition=fundamental","pubTime":"2025-04-24 22:01","pubTimestamp":1745503317,"startTime":"0","endTime":"0","summary":"The market expects Organon  to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 1, 2025, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This pharmaceutical company is expected to post quarterly earnings of $0.92 per share in its upcoming report, which represents a year-over-year change of -24.6%.Revenues are ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analysts-estimate-organon-ogn-report-140157968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OGN","ICLR"],"gpt_icon":0},{"id":"2529095386","title":"BofA Securities Adjusts Price Target on Organon to $11 From $15, Maintains Underperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2529095386","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529095386?lang=en_us&edition=fundamental","pubTime":"2025-04-21 23:12","pubTimestamp":1745248357,"startTime":"0","endTime":"0","summary":"Organon (OGN) has an average rating of hold and mean price target of $19.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OGN"],"gpt_icon":0},{"id":"2527782784","title":"Organon Appoints Ramona a. Sequeira to the Company’s Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2527782784","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527782784?lang=en_us&edition=fundamental","pubTime":"2025-04-16 05:00","pubTimestamp":1744750801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5DRXV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065170008.USD","LU2065169927.USD","BK4007","BK4559","LU2065171402.SGD","BK4585","LU2065171311.SGD","BK4588","OGN"],"gpt_icon":0},{"id":"2527473729","title":"Organon Appoints Ramona A. Sequeira to the Company’s Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2527473729","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527473729?lang=en_us&edition=fundamental","pubTime":"2025-04-16 05:00","pubTimestamp":1744750800,"startTime":"0","endTime":"0","summary":"JERSEY CITY, N.J., April 15, 2025----Organon  a global healthcare company with a focus on women’s health, today announced the appointment of Ramona A. Sequeira, President of the Global Portfolio Division at Takeda Pharmaceutical Company, to Organon’s Board of Directors, effective July 1, 2025. Ms. Sequeira will serve on the Board’s Talent Committee. In connection with Ms. Sequeira’s appointment, the size of Organon’s Board will be expanded to 12 directors.Ms. Sequeira brings more than 30 years of pharmaceutical industry expertise, with 20 years at Eli Lilly and Company and 10 years at Takeda. She is a proven commercial leader with a steadfast commitment to building strategies around the needs of patients and a track record of strong execution across global markets including the USA, Europe and Emerging Markets.\"We are excited to strengthen our Board with the appointment of Ramona Sequeira,\" said Carrie Cox, Chairman of Organon’s Board of Directors. \"Her deep experience in commercial st","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/organon-appoints-ramona-sequeira-company-210000329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065169927.USD","BK4585","LU2065171311.SGD","BK4588","OGN","BK4559","LU2065170008.USD","LU2065171402.SGD","BK4007"],"gpt_icon":0},{"id":"2527641171","title":"BRIEF-Organon & Co - Expects $6 Million Milestone Expense In Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527641171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527641171?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:18","pubTimestamp":1744723094,"startTime":"0","endTime":"0","summary":"BRIEF-Organon & Co - Expects $6 Million Milestone Expense In Q1 2025April 15 (Reuters) - Organon & Co OGN.N:ORGANON & CO - EXPECTS $6 MILLION MILESTONE EXPENSE IN Q1 2025Source text: ID:nBwbx3wzraFurther company coverage: OGN.N ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065169927.USD","BK4559","BK4585","OGN","BK4007","BK4588","LU2065171311.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"2527492556","title":"Press Release: Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527492556","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527492556?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:35","pubTimestamp":1744716900,"startTime":"0","endTime":"0","summary":"Organon , a global healthcare company with a primary focus on women's health, will release its first quarter 2025 financial results on May 1, 2025, prior to the company's webcast and conference call scheduled for 8:30 a.m. EDT.Organon currently expects that it will record approximately $6 million of milestone expense in the first quarter of 2025.Organon does not forecast IPR&D  or milestones due to the level of uncertainty and ability to forecast the timing of such achievements. As such, these milestones, as well as any future IPR&D and milestones are not contemplated in the company's financial guidance provided on February 13, 2025. Organon's first quarter 2025 results have not been finalized and are subject to the company's quarterly financial statement closing procedures. There can be no assurance that actual results will not differ from the preliminary estimates described herein.Organon has geographic scope with significant reach, world-class commercial capabilities, and approximat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4218","BK4007","LU2065171311.SGD","OGN","BK4585","BK4588","BK4181","HST","LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD"],"gpt_icon":0},{"id":"2527149407","title":"Organon & Co - Expects $6 Million Milestone Expense in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527149407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527149407?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:32","pubTimestamp":1744716731,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nFWN3QT0IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4559","BK4588","OGN","LU2065170008.USD","LU2065171402.SGD","BK4007","LU2065171311.SGD","LU2065169927.USD"],"gpt_icon":0},{"id":"2527916506","title":"Health Canada Approves Nduvra™ (Tapinarof Cream), 1%, for the Topical Treatment of Plaque Psoriasis in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2527916506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527916506?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:02","pubTimestamp":1744635735,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS237:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","BK4559","LU2065170008.USD","OGN","LU2065171311.SGD","LU2065169927.USD","BK4585","BK4588","BK4007"],"gpt_icon":0},{"id":"2526838365","title":"Morgan Stanley Sticks to Its Hold Rating for Organon (OGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2526838365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526838365?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:18","pubTimestamp":1744201092,"startTime":"0","endTime":"0","summary":"In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Organon (OGN – Research Report), with a price target of $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-organon-ogn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-hold-rating-for-organon-ogn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OGN"],"gpt_icon":0},{"id":"2525899321","title":"Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2525899321","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525899321?lang=en_us&edition=fundamental","pubTime":"2025-04-08 17:07","pubTimestamp":1744103238,"startTime":"0","endTime":"0","summary":"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon  and the best and worst performers in the branded pharmaceuticals industry.The 11 branded pharmaceuticals stocks we track reported a mixed Q4. As a group, revenues beat analysts’ consensus estimates by 1.3%.Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 5.7% since the latest earnings results.Spun off from Merck in 2021 to create a company dedicated to addressing unmet needs in women's health, Organon  is a global healthcare company focused on improving women's health through prescription therapies, medical devices, biosimilars, and established medicines.Organon reported revenues of $1.59 billion, flat year on year. This print exceeded analysts’ expectations by 0.9%. Despite the top-line beat, it was still a slower quarter for the company with full-year revenue guidance mi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-earnings-roundup-organon-nyse-090718154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MRK","SUPN","OGN","NYSE"],"gpt_icon":0},{"id":"2524147024","title":"Why Organon (OGN) Could Beat Earnings Estimates Again","url":"https://stock-news.laohu8.com/highlight/detail?id=2524147024","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524147024?lang=en_us&edition=fundamental","pubTime":"2025-04-03 00:10","pubTimestamp":1743610214,"startTime":"0","endTime":"0","summary":"If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Organon . This company, which is in the Zacks Medical Services industry, shows potential for another earnings beat.This pharmaceutical company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 3.50%.For the most recent quarter, Organon was expected to post earnings of $0.86 per share, but it reported $0.90 per share instead, representing a surprise of 4.65%. For the previous quarter, the consensus estimate was $0.85 per share, while it actually produced $0.87 per share, a surprise of 2.35%.For Organon, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP , it's a great indicator of a fu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-organon-ogn-could-beat-161014731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OGN"],"gpt_icon":0},{"id":"2524113078","title":"Organon Acquires Tofidence for Intravenous Infusion in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2524113078","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524113078?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:32","pubTimestamp":1743510770,"startTime":"0","endTime":"0","summary":"Organon  said Tuesday it acquired from Biogen  the regulatory and commercial rights to Tofidence for intravenous infusion in the US.Tofidence, a biosimilar to Actemra, is indicated for the treatment of arthritis and COVID-19, Organon said.The company said the deal includes an upfront payment to Biogen, with Organon assuming the obligation to pay tiered royalty payments based on net sales and tiered annual net sales milestone payments that Biogen owes to Bio-Thera Solutions, the product developer.Organon said Bio-Thera Solutions will keep manufacturing rights for Tofidence in the US.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","BK4559","BK4588","LU2065170008.USD","LU0109394709.USD","BK4139","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","OGN","LU0234570918.USD","LU2065171311.SGD","BK4585","BK4532","LU0889565916.HKD","BIIB","IE00B894F039.SGD","BK4533","LU2065171402.SGD","BK4007","LU2065169927.USD"],"gpt_icon":0},{"id":"2524978481","title":"Organon & Co - to Pay Tiered Royalties and Milestone Payments to Biogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2524978481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524978481?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:30","pubTimestamp":1743507001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA8PGT3D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4532","LU2065171402.SGD","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU2065170008.USD","BK4559","LU0320765992.SGD","BK4139","BK4585","BK4533","BIIB","LU2065169927.USD","IE00B19Z9P08.USD","LU0889565916.HKD","OGN","BK4007","LU0234570918.USD","LU0109394709.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2524978121","title":"Organon Acquires Tofidence™ (Tocilizumab-Bavi), a Commercialized Biosimilar to Actemra® (Tocilizumab) Injection, for Intravenous Infusion in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524978121","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524978121?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:30","pubTimestamp":1743507001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA8PGT3D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","OGN","BK4588","LU2065171402.SGD","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","BK4007","BK4585"],"gpt_icon":0},{"id":"2524810197","title":"Organon & Co - Bio-Thera Solutions to Maintain Manufacturing Rights for Tofidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2524810197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524810197?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:30","pubTimestamp":1743507001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA8PGT3D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","BK4559","OGN","BK4588","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4585","BK4007"],"gpt_icon":0},{"id":"2522577479","title":"Organon, Henlius Say EMA Validates Marketing Authorization Application for Proposed Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2522577479","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522577479?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:33","pubTimestamp":1743168809,"startTime":"0","endTime":"0","summary":"Organon  and Shanghai Henlius Biotech said Friday the European Medicines Agency has validated the marketing authorization application for HLX11, an investigational biosimilar of breast cancer drug Perjeta, or pertuzumab.The companies said that in several countries and regions, pertuzumab in combination with trastuzumab and chemotherapy has been approved for breast cancer treatment.They said the submission was based on a phase 3 clinical study that showed HLX11 meeting the primary endpoint of the total pathological complete response rate evaluated by an Independent Review Committee.The study, which compared the efficacy and safety of HLX11 with reference Perjeta, also showed that other secondary endpoint indicators were also comparable between the two groups, the companies said.Henlius granted Organon the exclusive commercialization rights to two biosimilar candidates, including HLX11, under a 2022 license and supply agreement that covers markets such as the US, the EU and Canada, the c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065170008.USD","BK4585","BK4007","BK1161","LU2065171402.SGD","BK4588","OGN","BK4559","02696","LU2065169927.USD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2522795425","title":"BRIEF-European Medicines Agency (EMA) Validates Henlius And Organon Filing For Perjeta® (Pertuzumab) Biosimilar Candidate HLX11","url":"https://stock-news.laohu8.com/highlight/detail?id=2522795425","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522795425?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:41","pubTimestamp":1743165677,"startTime":"0","endTime":"0","summary":"BRIEF-European Medicines Agency (EMA) Validates Henlius And Organon Filing For Perjeta (Pertuzumab) Biosimilar Candidate HLX11March 28 (Reuters) - Organon & Co OGN.N:EUROPEAN MEDICINES AGENCY (EMA) VA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA2MWR5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065171311.SGD","LU2065171402.SGD","OGN","BK4588","LU2065170008.USD","LU2065169927.USD","BK4585","BK4559"],"gpt_icon":0},{"id":"2522523081","title":"European Medicines Agency (Ema) Validates Henlius and Organon Filing for Perjeta® (Pertuzumab) Biosimilar Candidate Hlx11","url":"https://stock-news.laohu8.com/highlight/detail?id=2522523081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522523081?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:00","pubTimestamp":1743156000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA2MWR5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OGN","LU2065170008.USD","LU2065169927.USD","BK4559","BK4585","BK4007","BK4588","LU2065171402.SGD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2522255305","title":"European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11","url":"https://stock-news.laohu8.com/highlight/detail?id=2522255305","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522255305?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:00","pubTimestamp":1743156000,"startTime":"0","endTime":"0","summary":"SHANGHAI, China & JERSEY CITY, N.J., March 28, 2025----Shanghai Henlius Biotech, Inc.  and Organon  today announced that the European Medicines Agency  has validated the marketing authorization application  for HLX11, an investigational biosimilar of Perjeta . Pertuzumab has been approved in various countries and regions in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of patients with HER2-positive, locally advanced, inflammatory or early-stage breast cancer, and adjuvant treatment for certain HER2-positive early breast cancer, among other indications.In 2022, Henlius entered into a license and supply agreement with Organon, granting Organon the exclusive commercialization rights to two biosimilar candidates, including HLX11. The agreement covers markets such as the United States, the European Union, and Canada. An exception to the agreement is China.Henlius has pro-actively built a diversified and high-quality product pipeline covering about 50 molecules","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-medicines-agency-ema-validates-100000495.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4007","BK4559","LU2065169927.USD","BK4215","MAA","BK4588","OGN","MDCO","LU2065171311.SGD","LU2065171402.SGD","LU2065170008.USD"],"gpt_icon":0},{"id":"2518165299","title":"Barclays Sticks to Its Buy Rating for Organon (OGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518165299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518165299?lang=en_us&edition=fundamental","pubTime":"2025-03-10 15:28","pubTimestamp":1741591697,"startTime":"0","endTime":"0","summary":"In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Organon (OGN – Research Report), with a price target of $24.00. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-organon-ogn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-organon-ogn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OGN"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":86,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OGN\",params:#limit:5,,,undefined,":[{"date":"2025-05-01","symbol":"OGN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.86,"defaultRemindTime":1746086400000,"name":null,"time":"Pre-Market","dateTimestamp":1746072000000,"actualEps":null},{"date":"2025-02-24","symbol":"OGN","amount":0.28,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-24","defaultRemindTime":1740407400000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-13","payableDate":"2025-02-24","currency":"USD","dateTimestamp":1740373200000,"payDate":"2025-03-13"},{"market":"US","date":"2025-02-13","symbol":"OGN","fiscalQuarterEnding":"2024/12","expectedEps":0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"pre","actualEps":0.83},{"date":"2024-11-12","symbol":"OGN","amount":0.28,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-12","defaultRemindTime":1731421800000,"name":"Organon & Co","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-12","payableDate":"2024-11-12","currency":"USD","dateTimestamp":1731387600000,"payDate":"2024-12-12"},{"market":"US","date":"2024-10-31","symbol":"OGN","fiscalQuarterEnding":"2024/09","expectedEps":0.79,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OGN\",market:\"US\",,,undefined,":[{"executeDate":"2021-08-20","recordDate":"2021-08-23","paymentDate":"2021-09-13","value":0.28,"currency":"USD"},{"executeDate":"2021-11-19","recordDate":"2021-11-22","paymentDate":"2021-12-16","value":0.28,"currency":"USD"},{"executeDate":"2022-02-25","recordDate":"2022-02-28","paymentDate":"2022-03-17","value":0.28,"currency":"USD"},{"executeDate":"2022-05-13","recordDate":"2022-05-16","paymentDate":"2022-06-16","value":0.28,"currency":"USD"},{"executeDate":"2022-08-12","recordDate":"2022-08-15","paymentDate":"2022-09-15","value":0.28,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.375,"hold":0.25,"sell":0.375,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.25,"analysts":8,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OGN","date":"2025-04-25","current":3.618467,"percent":0.089397,"low":2.858464,"twenty":4.531955,"median":5.440407,"eighty":6.876603,"high":8.287792,"avg":5.581837,"sd":1.29378,"marketCap":3126355805},"quantilePoints":[{"date":"2021-05-14","current":3.896567,"twenty":3.896567,"median":3.896567,"eighty":3.896567,"marketCap":8416584968},{"date":"2021-05-21","current":4.406344,"twenty":3.996179,"median":4.394625,"eighty":4.406344,"marketCap":9517702100},{"date":"2021-05-28","current":4.189542,"twenty":4.160245,"median":4.33017,"eighty":4.406344,"marketCap":9049410906},{"date":"2021-06-04","current":4.002038,"twenty":4.106103,"median":4.316107,"eighty":4.396969,"marketCap":8644402306},{"date":"2021-06-11","current":3.474683,"twenty":3.656562,"median":4.174893,"eighty":4.394625,"marketCap":7505315618},{"date":"2021-06-18","current":3.513356,"twenty":3.5532,"median":4.002038,"eighty":4.347749,"marketCap":7588848642},{"date":"2021-06-25","current":4.123733,"twenty":3.589061,"median":4.031533,"eighty":4.331342,"marketCap":7653648040},{"date":"2021-07-02","current":4.21525,"twenty":3.665234,"median":4.123733,"eighty":4.31892,"marketCap":7823503760},{"date":"2021-07-09","current":4.111439,"twenty":3.684922,"median":4.114171,"eighty":4.267067,"marketCap":7630831600},{"date":"2021-07-16","current":3.94343,"twenty":3.711407,"median":4.064315,"eighty":4.229455,"marketCap":7319006920},{"date":"2021-07-23","current":4.070462,"twenty":3.829066,"median":4.066364,"eighty":4.224538,"marketCap":7554776800},{"date":"2021-07-30","current":3.962553,"twenty":3.924685,"median":4.056802,"eighty":4.220682,"marketCap":7354499160},{"date":"2021-08-06","current":4.029484,"twenty":3.930317,"median":4.044509,"eighty":4.216686,"marketCap":7478722000},{"date":"2021-08-13","current":4.981495,"twenty":3.946708,"median":4.050656,"eighty":4.220682,"marketCap":8672782360},{"date":"2021-08-20","current":4.83789,"twenty":3.957089,"median":4.062266,"eighty":4.321732,"marketCap":8422766594},{"date":"2021-08-27","current":4.987891,"twenty":3.969929,"median":4.07934,"eighty":4.399313,"marketCap":8683917996},{"date":"2021-09-03","current":5.18595,"twenty":3.974847,"median":4.114171,"eighty":4.832647,"marketCap":9028739266},{"date":"2021-09-10","current":4.934007,"twenty":3.97594,"median":4.132119,"eighty":4.866681,"marketCap":8590106327},{"date":"2021-09-17","current":4.955852,"twenty":3.978671,"median":4.152916,"eighty":4.910706,"marketCap":8628138085},{"date":"2021-09-24","current":4.906337,"twenty":3.985228,"median":4.172906,"eighty":4.908958,"marketCap":8541932768},{"date":"2021-10-01","current":4.85391,"twenty":3.994034,"median":4.212518,"eighty":4.908958,"marketCap":8450656549},{"date":"2021-10-08","current":4.743229,"twenty":3.998523,"median":4.223445,"eighty":4.900512,"marketCap":8257962311},{"date":"2021-10-15","current":5.081095,"twenty":4.004274,"median":4.27524,"eighty":4.903424,"marketCap":8846186829},{"date":"2021-10-22","current":5.193232,"twenty":4.011453,"median":4.33603,"eighty":4.922647,"marketCap":9041416518},{"date":"2021-10-29","current":5.35197,"twenty":4.022108,"median":4.400484,"eighty":4.947405,"marketCap":9317780624},{"date":"2021-11-05","current":5.283524,"twenty":4.029484,"median":4.45322,"eighty":4.985333,"marketCap":9198614450},{"date":"2021-11-12","current":5.632588,"twenty":4.03003,"median":4.749054,"eighty":5.060998,"marketCap":8544635977},{"date":"2021-11-19","current":5.223097,"twenty":4.031943,"median":4.78255,"eighty":5.132066,"marketCap":7923438406},{"date":"2021-11-26","current":5.20304,"twenty":4.033582,"median":4.789832,"eighty":5.18595,"marketCap":7893012402},{"date":"2021-12-03","current":4.818621,"twenty":4.034401,"median":4.79951,"eighty":5.179251,"marketCap":7309847336},{"date":"2021-12-10","current":4.803578,"twenty":4.039045,"median":4.803578,"eighty":5.151872,"marketCap":7287027833},{"date":"2021-12-17","current":5.04593,"twenty":4.045602,"median":4.817333,"eighty":5.143194,"marketCap":7654675375},{"date":"2021-12-23","current":5.050944,"twenty":4.049973,"median":4.823635,"eighty":5.1178,"marketCap":7662281876},{"date":"2021-12-31","current":5.089386,"twenty":4.051339,"median":4.829152,"eighty":5.1178,"marketCap":7720598383},{"date":"2022-01-07","current":5.416979,"twenty":4.062266,"median":4.839346,"eighty":5.18595,"marketCap":8217556439},{"date":"2022-01-14","current":5.492191,"twenty":4.062266,"median":4.85391,"eighty":5.198026,"marketCap":8331653952},{"date":"2022-01-21","current":5.176298,"twenty":4.065544,"median":4.867016,"eighty":5.203991,"marketCap":7852444398},{"date":"2022-01-28","current":5.256525,"twenty":4.069642,"median":4.884984,"eighty":5.203991,"marketCap":7974148412},{"date":"2022-02-04","current":5.535647,"twenty":4.084668,"median":4.898847,"eighty":5.229783,"marketCap":8397576960},{"date":"2022-02-11","current":5.80307,"twenty":4.106795,"median":4.900622,"eighty":5.273377,"marketCap":8803257006},{"date":"2022-02-18","current":6.77322,"twenty":4.113625,"median":4.906337,"eighty":5.293446,"marketCap":9150620546},{"date":"2022-02-25","current":7.05098,"twenty":4.119908,"median":4.910706,"eighty":5.324449,"marketCap":9525874589},{"date":"2022-03-04","current":7.285575,"twenty":4.128765,"median":4.921628,"eighty":5.348475,"marketCap":9842812125},{"date":"2022-03-11","current":6.724425,"twenty":4.132824,"median":4.935463,"eighty":5.378584,"marketCap":9084697539},{"date":"2022-03-18","current":6.583668,"twenty":4.14067,"median":4.952211,"eighty":5.411178,"marketCap":8894535017},{"date":"2022-03-25","current":6.569034,"twenty":4.154382,"median":4.966046,"eighty":5.494865,"marketCap":8874764893},{"date":"2022-04-01","current":6.599072,"twenty":4.160466,"median":4.982791,"eighty":5.52261,"marketCap":8915346841},{"date":"2022-04-08","current":6.734245,"twenty":4.167989,"median":4.995788,"eighty":5.60384,"marketCap":9097965610},{"date":"2022-04-14","current":6.552137,"twenty":4.17956,"median":5.015845,"eighty":5.704124,"marketCap":8851937547},{"date":"2022-04-22","current":6.056503,"twenty":4.19764,"median":5.039484,"eighty":5.803024,"marketCap":8182335394},{"date":"2022-04-29","current":6.069645,"twenty":4.211972,"median":5.050944,"eighty":6.058632,"marketCap":8200089997},{"date":"2022-05-06","current":6.783819,"twenty":4.216686,"median":5.075212,"eighty":6.073577,"marketCap":8818964713},{"date":"2022-05-13","current":6.816987,"twenty":4.220682,"median":5.089386,"eighty":6.132725,"marketCap":8862083034},{"date":"2022-05-20","current":7.343772,"twenty":4.224538,"median":5.111826,"eighty":6.249124,"marketCap":9546903417},{"date":"2022-05-27","current":7.589605,"twenty":4.229455,"median":5.132842,"eighty":6.481977,"marketCap":9866486263},{"date":"2022-06-03","current":7.254023,"twenty":4.25072,"median":5.136185,"eighty":6.547256,"marketCap":9430230315},{"date":"2022-06-10","current":6.918442,"twenty":4.31892,"median":5.164376,"eighty":6.569034,"marketCap":8993974367},{"date":"2022-06-17","current":6.47165,"twenty":4.331342,"median":5.18595,"eighty":6.569034,"marketCap":8413145227},{"date":"2022-06-24","current":6.996484,"twenty":4.33603,"median":5.193232,"eighty":6.583668,"marketCap":9095429238},{"date":"2022-07-01","current":6.682364,"twenty":4.394625,"median":5.202505,"eighty":6.604705,"marketCap":8687073380},{"date":"2022-07-08","current":6.389706,"twenty":4.394625,"median":5.207925,"eighty":6.609211,"marketCap":8306617612},{"date":"2022-07-15","current":6.237524,"twenty":4.404,"median":5.223097,"eighty":6.603203,"marketCap":8108780612},{"date":"2022-07-22","current":6.235572,"twenty":4.420406,"median":5.267389,"eighty":6.599823,"marketCap":8106244240},{"date":"2022-07-29","current":6.188747,"twenty":4.44736,"median":5.280611,"eighty":6.587663,"marketCap":8045371317},{"date":"2022-08-05","current":7.237028,"twenty":4.680567,"median":5.285902,"eighty":6.599823,"marketCap":8011390369},{"date":"2022-08-12","current":7.119857,"twenty":4.742064,"median":5.318366,"eighty":6.631739,"marketCap":7881682144},{"date":"2022-08-19","current":7.044041,"twenty":4.75255,"median":5.333952,"eighty":6.664515,"marketCap":7797753292},{"date":"2022-08-26","current":6.821186,"twenty":4.77119,"median":5.346145,"eighty":6.72327,"marketCap":7551053335},{"date":"2022-09-02","current":6.547788,"twenty":4.781094,"median":5.361158,"eighty":6.72327,"marketCap":7248400810},{"date":"2022-09-09","current":6.853351,"twenty":4.78255,"median":5.379411,"eighty":6.728353,"marketCap":7586659514},{"date":"2022-09-16","current":6.57306,"twenty":4.786919,"median":5.388565,"eighty":6.728353,"marketCap":7276377094},{"date":"2022-09-23","current":5.915983,"twenty":4.79106,"median":5.433693,"eighty":6.723559,"marketCap":6548993714},{"date":"2022-09-30","current":5.376078,"twenty":4.795019,"median":5.450406,"eighty":6.698611,"marketCap":5951318560},{"date":"2022-10-07","current":5.516224,"twenty":4.797113,"median":5.495534,"eighty":6.676511,"marketCap":6106459770},{"date":"2022-10-14","current":5.355401,"twenty":4.799989,"median":5.473806,"eighty":6.672609,"marketCap":5928428873},{"date":"2022-10-21","current":5.440407,"twenty":4.80291,"median":5.469126,"eighty":6.666539,"marketCap":6022530919},{"date":"2022-10-28","current":6.014775,"twenty":4.808437,"median":5.492191,"eighty":6.657079,"marketCap":6658355551},{"date":"2022-11-04","current":6.126383,"twenty":4.814297,"median":5.504727,"eighty":6.648993,"marketCap":6193773359},{"date":"2022-11-11","current":6.367916,"twenty":4.817591,"median":5.516224,"eighty":6.640375,"marketCap":6437963191},{"date":"2022-11-18","current":6.138963,"twenty":4.820626,"median":5.526562,"eighty":6.635494,"marketCap":6206491579},{"date":"2022-11-25","current":6.317597,"twenty":4.8233,"median":5.544315,"eighty":6.633241,"marketCap":6387090309},{"date":"2022-12-02","current":6.722668,"twenty":4.826262,"median":5.573661,"eighty":6.635869,"marketCap":6796617008},{"date":"2022-12-09","current":6.805695,"twenty":4.828278,"median":5.604174,"eighty":6.642253,"marketCap":6880557263},{"date":"2022-12-16","current":6.903817,"twenty":4.832065,"median":5.632588,"eighty":6.668562,"marketCap":6979759382},{"date":"2022-12-23","current":7.0271,"twenty":4.837016,"median":5.685088,"eighty":6.722856,"marketCap":7104397943},{"date":"2022-12-30","current":7.0271,"twenty":4.838473,"median":5.752092,"eighty":6.741307,"marketCap":7104397943},{"date":"2023-01-06","current":7.334048,"twenty":4.840803,"median":5.779739,"eighty":6.752576,"marketCap":7414722522},{"date":"2023-01-13","current":8.066195,"twenty":4.849541,"median":5.80307,"eighty":6.76196,"marketCap":8154922952},{"date":"2023-01-20","current":7.885045,"twenty":4.853036,"median":5.886639,"eighty":6.782258,"marketCap":7971780578},{"date":"2023-01-27","current":7.53281,"twenty":4.859735,"median":5.911388,"eighty":6.797626,"marketCap":7615670405},{"date":"2023-02-03","current":7.487522,"twenty":4.865851,"median":5.943859,"eighty":6.817827,"marketCap":7569884811},{"date":"2023-02-10","current":7.30134,"twenty":4.87589,"median":5.981259,"eighty":6.844798,"marketCap":7381655149},{"date":"2023-02-17","current":7.217625,"twenty":4.883215,"median":6.014775,"eighty":6.899163,"marketCap":6618561922},{"date":"2023-02-24","current":7.098348,"twenty":4.885082,"median":6.02271,"eighty":6.906249,"marketCap":6509185226},{"date":"2023-03-03","current":6.81313,"twenty":4.889255,"median":6.048275,"eighty":6.906249,"marketCap":6247639897},{"date":"2023-03-10","current":6.291603,"twenty":4.896018,"median":6.063022,"eighty":6.904767,"marketCap":5769400361},{"date":"2023-03-17","current":6.011422,"twenty":4.898847,"median":6.061537,"eighty":6.902307,"marketCap":5512473802},{"date":"2023-03-24","current":6.064129,"twenty":4.898972,"median":6.063022,"eighty":6.899698,"marketCap":5560806521},{"date":"2023-03-31","current":6.524626,"twenty":4.900936,"median":6.071417,"eighty":6.886443,"marketCap":5983081856},{"date":"2023-04-06","current":6.557915,"twenty":4.90219,"median":6.080188,"eighty":6.876603,"marketCap":6013607784},{"date":"2023-04-14","current":6.652233,"twenty":4.903849,"median":6.089096,"eighty":6.865757,"marketCap":6100097913},{"date":"2023-04-21","current":6.571785,"twenty":4.906684,"median":6.114299,"eighty":6.849075,"marketCap":6026326921},{"date":"2023-04-28","current":6.767337,"twenty":4.908605,"median":6.136447,"eighty":6.835908,"marketCap":6205648387},{"date":"2023-05-05","current":7.525343,"twenty":4.910706,"median":6.154734,"eighty":6.852323,"marketCap":5613905507},{"date":"2023-05-12","current":7.231308,"twenty":4.913036,"median":6.169544,"eighty":6.900232,"marketCap":5394555949},{"date":"2023-05-19","current":6.998812,"twenty":4.920609,"median":6.176067,"eighty":6.910087,"marketCap":5221113961},{"date":"2023-05-26","current":6.79025,"twenty":4.929638,"median":6.195431,"eighty":6.916101,"marketCap":5065526295},{"date":"2023-06-02","current":6.650068,"twenty":4.934298,"median":6.198502,"eighty":6.912589,"marketCap":4960950979},{"date":"2023-06-09","current":6.841536,"twenty":4.937502,"median":6.209295,"eighty":6.912589,"marketCap":5103785557},{"date":"2023-06-16","current":7.15267,"twenty":4.94624,"median":6.214111,"eighty":6.938687,"marketCap":5335891747},{"date":"2023-06-23","current":7.149251,"twenty":4.94857,"median":6.219474,"eighty":6.960156,"marketCap":5333341129},{"date":"2023-06-30","current":7.087708,"twenty":4.954396,"median":6.23457,"eighty":6.972651,"marketCap":5287430015},{"date":"2023-07-07","current":6.810764,"twenty":4.957751,"median":6.237524,"eighty":6.979666,"marketCap":5080830000},{"date":"2023-07-14","current":7.08087,"twenty":4.963234,"median":6.25344,"eighty":6.981717,"marketCap":5282328780},{"date":"2023-07-21","current":7.145832,"twenty":4.973863,"median":6.266772,"eighty":6.993719,"marketCap":5330790512},{"date":"2023-07-28","current":7.480899,"twenty":4.980527,"median":6.283214,"eighty":7.009926,"marketCap":5580751024},{"date":"2023-08-04","current":7.354394,"twenty":4.983051,"median":6.298006,"eighty":7.022062,"marketCap":5486378177},{"date":"2023-08-11","current":8.00261,"twenty":4.98637,"median":6.34288,"eighty":7.029904,"marketCap":6033968058},{"date":"2023-08-18","current":7.606039,"twenty":4.992629,"median":6.368244,"eighty":7.03947,"marketCap":5734953123},{"date":"2023-08-25","current":7.32471,"twenty":4.99804,"median":6.384829,"eighty":7.061003,"marketCap":5522831416},{"date":"2023-09-01","current":7.443343,"twenty":5.009323,"median":6.401412,"eighty":7.09045,"marketCap":5612280329},{"date":"2023-09-08","current":6.599357,"twenty":5.018519,"median":6.403954,"eighty":7.092056,"marketCap":4975915209},{"date":"2023-09-15","current":6.707821,"twenty":5.029216,"median":6.413118,"eighty":7.091127,"marketCap":5057697072},{"date":"2023-09-22","current":6.297692,"twenty":5.033037,"median":6.41507,"eighty":7.089999,"marketCap":4748459404},{"date":"2023-09-27","current":5.846888,"twenty":5.040773,"median":6.412051,"eighty":7.088624,"marketCap":4408553537},{"date":"2023-10-06","current":5.497769,"twenty":5.04868,"median":6.402566,"eighty":7.083605,"marketCap":4145318166},{"date":"2023-10-13","current":5.640128,"twenty":5.050772,"median":6.394583,"eighty":7.069742,"marketCap":4252656861},{"date":"2023-10-20","current":5.470653,"twenty":5.06117,"median":6.373784,"eighty":7.061003,"marketCap":4124872700},{"date":"2023-10-27","current":5.189325,"twenty":5.067988,"median":6.368244,"eighty":7.060123,"marketCap":3912750994},{"date":"2023-11-03","current":5.727352,"twenty":5.066495,"median":6.367916,"eighty":7.054838,"marketCap":3350500688},{"date":"2023-11-10","current":4.989788,"twenty":5.066495,"median":6.324385,"eighty":7.051487,"marketCap":2919025784},{"date":"2023-11-17","current":4.784429,"twenty":5.049596,"median":6.297692,"eighty":7.045429,"marketCap":2798890747},{"date":"2023-11-24","current":4.963572,"twenty":5.023868,"median":6.291603,"eighty":7.03947,"marketCap":2903689396},{"date":"2023-12-01","current":4.946094,"twenty":4.995136,"median":6.269431,"eighty":7.034371,"marketCap":2893465138},{"date":"2023-12-08","current":4.950464,"twenty":4.989029,"median":6.259729,"eighty":7.033003,"marketCap":2896021203},{"date":"2023-12-15","current":5.601495,"twenty":4.986902,"median":6.239821,"eighty":7.031403,"marketCap":3276874830},{"date":"2023-12-22","current":5.942304,"twenty":4.989029,"median":6.23457,"eighty":7.029904,"marketCap":3476247869},{"date":"2023-12-29","current":6.326806,"twenty":4.990662,"median":6.232836,"eighty":7.029113,"marketCap":3701181555},{"date":"2024-01-05","current":6.020952,"twenty":4.993283,"median":6.23457,"eighty":7.027603,"marketCap":3522257032},{"date":"2024-01-12","current":7.353601,"twenty":4.995462,"median":6.239821,"eighty":7.033003,"marketCap":4301856738},{"date":"2024-01-19","current":6.855496,"twenty":4.99804,"median":6.25344,"eighty":7.034371,"marketCap":4010465373},{"date":"2024-01-26","current":7.357971,"twenty":5.004175,"median":6.266772,"eighty":7.046817,"marketCap":4304412803},{"date":"2024-02-02","current":7.532744,"twenty":5.012413,"median":6.283214,"eighty":7.068727,"marketCap":4406655387},{"date":"2024-02-09","current":7.126396,"twenty":5.021183,"median":6.296221,"eighty":7.088624,"marketCap":4168941378},{"date":"2024-02-16","current":4.652387,"twenty":5.012413,"median":6.296957,"eighty":7.09045,"marketCap":4759392303},{"date":"2024-02-23","current":4.634897,"twenty":4.994809,"median":6.291603,"eighty":7.089083,"marketCap":4741499851},{"date":"2024-03-01","current":4.350598,"twenty":4.98462,"median":6.272091,"eighty":7.084973,"marketCap":4450662036},{"date":"2024-03-08","current":4.555509,"twenty":4.964562,"median":6.260435,"eighty":7.079855,"marketCap":4660285406},{"date":"2024-03-15","current":4.587995,"twenty":4.952619,"median":6.242118,"eighty":7.071929,"marketCap":4693518380},{"date":"2024-03-22","current":4.573001,"twenty":4.943298,"median":6.235071,"eighty":7.061443,"marketCap":4678180084},{"date":"2024-03-28","current":4.610485,"twenty":4.934298,"median":6.225288,"eighty":7.058802,"marketCap":4716525823},{"date":"2024-04-05","current":4.465548,"twenty":4.910706,"median":6.214111,"eighty":7.05301,"marketCap":4568255634},{"date":"2024-04-12","current":4.568003,"twenty":4.903019,"median":6.209295,"eighty":7.049592,"marketCap":4673067319},{"date":"2024-04-19","current":4.463049,"twenty":4.898847,"median":6.198502,"eighty":7.043908,"marketCap":4565699252},{"date":"2024-04-26","current":4.630616,"twenty":4.884689,"median":6.192329,"eighty":7.041987,"marketCap":4737120415},{"date":"2024-05-03","current":4.789749,"twenty":4.859204,"median":6.177041,"eighty":7.035738,"marketCap":5014866889},{"date":"2024-05-10","current":5.037795,"twenty":4.859204,"median":6.174207,"eighty":7.033003,"marketCap":5274571610},{"date":"2024-05-17","current":5.285878,"twenty":4.862356,"median":6.159481,"eighty":7.03247,"marketCap":5534314045},{"date":"2024-05-24","current":5.244121,"twenty":4.869234,"median":6.145607,"eighty":7.030192,"marketCap":5490595021},{"date":"2024-05-31","current":5.143415,"twenty":4.878108,"median":6.131415,"eighty":7.029616,"marketCap":5385155023},{"date":"2024-06-07","current":5.077095,"twenty":4.884492,"median":6.103438,"eighty":7.0271,"marketCap":5315718927},{"date":"2024-06-14","current":5.037795,"twenty":4.885279,"median":6.089096,"eighty":7.0271,"marketCap":5274571610},{"date":"2024-06-21","current":5.023058,"twenty":4.887766,"median":6.086541,"eighty":7.026539,"marketCap":5259141367},{"date":"2024-06-28","current":5.057445,"twenty":4.889293,"median":6.077754,"eighty":7.026165,"marketCap":5295145268},{"date":"2024-07-05","current":4.98867,"twenty":4.891278,"median":6.073189,"eighty":7.020695,"marketCap":5223137465},{"date":"2024-07-12","current":5.128677,"twenty":4.892656,"median":6.063576,"eighty":7.016661,"marketCap":5369724779},{"date":"2024-07-15","current":5.23184,"twenty":4.892876,"median":6.063022,"eighty":7.015995,"marketCap":5477736485},{"date":"2024-08-02","current":5.317809,"twenty":4.893367,"median":6.062188,"eighty":7.015978,"marketCap":5567746239},{"date":"2024-08-09","current":5.036181,"twenty":4.893367,"median":6.060052,"eighty":7.015908,"marketCap":5036181210},{"date":"2024-08-16","current":5.206114,"twenty":4.896035,"median":6.039186,"eighty":7.014411,"marketCap":5206113704},{"date":"2024-08-23","current":5.378621,"twenty":4.898847,"median":6.02271,"eighty":7.007926,"marketCap":5378620934},{"date":"2024-08-30","current":5.744233,"twenty":4.898889,"median":6.016486,"eighty":7.004513,"marketCap":5744233271},{"date":"2024-09-06","current":5.499633,"twenty":4.899055,"median":6.013098,"eighty":6.998812,"marketCap":5499633468},{"date":"2024-09-13","current":5.224137,"twenty":4.90219,"median":5.969811,"eighty":6.998812,"marketCap":5224136848},{"date":"2024-09-20","current":5.195815,"twenty":4.90219,"median":5.950598,"eighty":6.996484,"marketCap":5195814765},{"date":"2024-09-27","current":4.935767,"twenty":4.90219,"median":5.94207,"eighty":6.991876,"marketCap":4935766554},{"date":"2024-10-04","current":4.701466,"twenty":4.89972,"median":5.921803,"eighty":6.985136,"marketCap":4701465690},{"date":"2024-10-11","current":4.629373,"twenty":4.895332,"median":5.906794,"eighty":6.981717,"marketCap":4629373116},{"date":"2024-10-18","current":4.541832,"twenty":4.885476,"median":5.885406,"eighty":6.981717,"marketCap":4541832134},{"date":"2024-10-25","current":4.433693,"twenty":4.861191,"median":5.860446,"eighty":6.978298,"marketCap":4433693273},{"date":"2024-10-31","current":4.616499,"twenty":4.849278,"median":5.836719,"eighty":6.977591,"marketCap":4616499442},{"date":"2024-11-08","current":3.191027,"twenty":4.837599,"median":5.806685,"eighty":6.972651,"marketCap":4151526665},{"date":"2024-11-15","current":3.030684,"twenty":4.824637,"median":5.785429,"eighty":6.97071,"marketCap":3942920176},{"date":"2024-11-22","current":2.947543,"twenty":4.818243,"median":5.774058,"eighty":6.968537,"marketCap":3834753848},{"date":"2024-11-29","current":3.141539,"twenty":4.813679,"median":5.757525,"eighty":6.96331,"marketCap":4087141946},{"date":"2024-12-06","current":3.080173,"twenty":4.799989,"median":5.748592,"eighty":6.958054,"marketCap":4007304895},{"date":"2024-12-13","current":3.038602,"twenty":4.79106,"median":5.742774,"eighty":6.955143,"marketCap":3953221731},{"date":"2024-12-20","current":2.858464,"twenty":4.783334,"median":5.727352,"eighty":6.950007,"marketCap":3718861355},{"date":"2024-12-27","current":2.959421,"twenty":4.763035,"median":5.715098,"eighty":6.943968,"marketCap":3850206181},{"date":"2025-01-03","current":2.9614,"twenty":4.738569,"median":5.688534,"eighty":6.938687,"marketCap":3852781570},{"date":"2025-01-10","current":3.167273,"twenty":4.701466,"median":5.681642,"eighty":6.937269,"marketCap":4120622000},{"date":"2025-01-17","current":3.202905,"twenty":4.674875,"median":5.640536,"eighty":6.930431,"marketCap":4166978997},{"date":"2025-01-24","current":3.248434,"twenty":4.66027,"median":5.631842,"eighty":6.922225,"marketCap":4226212938},{"date":"2025-01-31","current":3.161334,"twenty":4.640892,"median":5.605846,"eighty":6.918788,"marketCap":4112895833},{"date":"2025-02-07","current":2.947543,"twenty":4.630473,"median":5.590299,"eighty":6.91376,"marketCap":3834753848},{"date":"2025-02-14","current":4.864623,"twenty":4.626977,"median":5.572338,"eighty":6.912589,"marketCap":4203034440},{"date":"2025-02-21","current":4.676834,"twenty":4.621405,"median":5.552983,"eighty":6.908835,"marketCap":4040784948},{"date":"2025-02-28","current":4.483084,"twenty":4.616931,"median":5.530836,"eighty":6.906249,"marketCap":3873384680},{"date":"2025-03-07","current":4.436504,"twenty":4.610485,"median":5.521496,"eighty":6.904767,"marketCap":3833139214},{"date":"2025-03-14","current":4.466359,"twenty":4.605995,"median":5.518522,"eighty":6.903374,"marketCap":3858934229},{"date":"2025-03-21","current":4.657433,"twenty":4.605995,"median":5.507234,"eighty":6.903079,"marketCap":4024022324},{"date":"2025-03-28","current":4.346938,"twenty":4.585996,"median":5.499255,"eighty":6.902012,"marketCap":3755754169},{"date":"2025-04-04","current":4.314097,"twenty":4.569713,"median":5.492191,"eighty":6.899698,"marketCap":3727379653},{"date":"2025-04-11","current":3.412466,"twenty":4.556765,"median":5.47223,"eighty":6.886939,"marketCap":2948370203},{"date":"2025-04-17","current":3.230348,"twenty":4.539542,"median":5.469126,"eighty":6.878815,"marketCap":2791020612},{"date":"2025-04-25","current":3.618467,"twenty":4.531955,"median":5.440407,"eighty":6.876603,"marketCap":3126355805}],"updateTime":1745734461955}}}